ROR1 and cancer: For instance, the therapeutic relevance of targeting the non-canonical Wnt receptors ROR1 and ROR2 (receptor tyrosine kinase-like orphan receptor) has been investigated in numerous cancers of both hematological and epithelial origin [11, 12].